+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Homocystinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Homocystinuria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Severe Acne Vulgaris - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Acne Vulgaris - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Propionic Acidemia - Pipeline Insight, 2025 - Product Thumbnail Image

Propionic Acidemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
GM2 Gangliosidosis - Pipeline Insight, 2025 - Product Thumbnail Image

GM2 Gangliosidosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Delayed Cerebral Ischaemia (DCI) - Pipeline Insight, 2025 - Product Thumbnail Image

Delayed Cerebral Ischaemia (DCI) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
ARDS - Pipeline Insight, 2025 - Product Thumbnail Image

ARDS - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acne - Pipeline Insight, 2025 - Product Thumbnail Image

Acne - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Allergy Sinus Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Allergy Sinus Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Alternating Hemiplegia Of Childhood (AHC) - Pipeline Insight, 2025 - Product Thumbnail Image

Alternating Hemiplegia Of Childhood (AHC) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neuroendocrine Tumours - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumours - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Autosomal Dominant Optic Atrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Autosomal Dominant Optic Atrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Bleeding Control - Pipeline Insight, 2025 - Product Thumbnail Image

Bleeding Control - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acute Muscle Injuries - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Muscle Injuries - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Cardiometabolic Risk Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cardiometabolic Risk Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Bunion - Pipeline Insight, 2025 - Product Thumbnail Image

Bunion - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Macular Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Macular Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Farber's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Farber's Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gender Dysphoria - Pipeline Insight, 2025 - Product Thumbnail Image

Gender Dysphoria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
GNE Myopathy - Pipeline Insight, 2025 - Product Thumbnail Image

GNE Myopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more